Jiezhong Chen
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 10
- Cancer Research top 2%
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer 16
- Gut microbiota and health 12
- Metabolism, Diabetes, and Cancer 11
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 7
- Immunology top 5%
-
- Plant Physiology and Cultivation Studies 10
-
- Liver Disease Diagnosis and Treatment 7
-
- Diet and metabolism studies 6
Jiezhong Chen
140 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Oncology 1.4k
- Cancer Research 677
- Molecular Biology 2.6k
- Pharmacology 316
- Immunology 723
Countries citing papers authored by Jiezhong Chen
This map shows the geographic impact of Jiezhong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiezhong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiezhong Chen more than expected).
Fields of papers citing papers by Jiezhong Chen
This network shows the impact of papers produced by Jiezhong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiezhong Chen. The network helps show where Jiezhong Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiezhong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 28 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 32 | |
| 4 | 2022 | 25 | |
| 5 | Nitrogen Permease Regulator-Like-2 Exhibited Anti-Tumor Effects And Enhanced The Sensitivity Of Colorectal Cancer Cells To Oxaliplatin And 5-Fluorouracil | 2019 | 1 |
| 6 | Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma | 2019 | 1 |
| 7 | Regulation of PD-L1: a novel role of pro-survival signalling in cancerbreakdown → | 2015 | 629 |
| 8 | 2014 | 23 | |
| 9 | The key regulatory roles of the PI3K/Akt signalling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration | 2013 | 3 |
| 10 | Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration | 2013 | 2 |
| 11 | 2013 | 3 | |
| 12 | 2013 | 22 | |
| 13 | 2013 | 203 | |
| 14 | 2013 | 5 | |
| 15 | The roles of miRNA-143 in colon cancer and therapeutic implications | 2012 | 15 |
| 16 | 2012 | 11 | |
| 17 | Targeted therapy of obesity-associated colon cancer | 2012 | 14 |
| 18 | 2010 | 3 | |
| 19 | 2006 | 2 | |
| 20 | The statistic inversion algorithms of water constituents for the Huanghai Sea and the East China Sea | 2004 | 39 |
About Jiezhong Chen
Jiezhong Chen is a scholar working on Oncology, Pharmacology and Horticulture, having authored 143 papers that have together received 6.7k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (16 papers), Gut microbiota and health (12 papers), Metabolism, Diabetes, and Cancer (11 papers), Drug Transport and Resistance Mechanisms (10 papers), Plant Physiology and Cultivation Studies (10 papers), Pharmacogenetics and Drug Metabolism (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Diet and metabolism studies (6 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (677 citations) and Molecular Biology (2.6k citations). Jiezhong Chen has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Luis Vitetta, Xu‐Feng Huang, Robert J. Seviour, Xu Dong Zhang, Chen Chen, Lei Jin, Chen Chen Jiang, Kong‐Nan Zhao, Kenneth Raymond and Wenyi Gu. Their work appears in journals such as Journal of Cellular Biochemistry, Reviews in Medical Virology, Scientia Horticulturae, International Journal of Molecular Sciences and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.